Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2

被引：7

作者：

Ahn, Terrie S. ^{[1
]}

Han, Brandon ^{[2
,3
]}

Krogstad, Paul ^{[2
,4
]}

Bun, Chantana ^{[1
]}

Kohn, Lisa A. ^{[1
]}

Garcia-Lloret, Maria I. ^{[1
]}

Damoiseaux, Robert ^{[2
,3
,5
]}

Butte, Manish J. ^{[1
,6
]}

机构：

[1] Univ Calif Los Angeles, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90024 USA

[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA USA

[4] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA

[5] Univ Calif Los Angeles, Dept Bioengn, Samueli Sch Engn, Los Angeles, CA USA

[6] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 03期

关键词：

INTRAVENOUS IMMUNOGLOBULIN;

D O I：

10.1016/j.jaci.2020.12.003

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：876 / 877

页数：2

共 50 条

[31] Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Tang, Mei San
Case, James Brett
Franks, Caroline E.
Chen, Rita E.
Anderson, Neil W.
Henderson, Jeffrey P.
Diamond, Michael S.
Gronowski, Ann M.
Farnsworth, Christopher W.
CLINICAL CHEMISTRY, 2020, 66 (12) : 1538 - 1547
[32] SARS-CoV-2 Neutralizing Antibodies 2.0
Wang, Youchun
VIRUSES-BASEL, 2024, 16 (11):
[33] Oral tablet vaccination against SARS-CoV-2 spike boosts cross-reactive serum and mucosal neutralizing antibodies following mRNA vaccination: a phase 2 clinical trial
Johnson, Susan
Jegede, Clara B.
Gutierrez, Samanta
Greco, Susan
Cummings, James
Gottlieb, Keith A.
Tucker, Sean N.
JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
[34] Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Clark, Jordan J.
Hoxie, Irene
Adelsberg, Daniel C.
Sapse, Iden A.
Andreata-Santos, Robert
Yong, Jeremy S.
Amanat, Fatima
Tcheou, Johnstone
Raskin, Ariel
Singh, Gagandeep
Gonzalez-Dominguez, Irene
Edgar, Julia E.
Bournazos, Stylianos
Sun, Weina
Carreno, Juan Manuel
Simon, Viviana
Ellebedy, Ali H.
Bajic, Goran
Krammer, Florian
CELL REPORTS, 2024, 43 (11):
[35] Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Crowley, Andrew R.
Natarajan, Harini
Hederman, Andrew P.
Bobak, Carly A.
Weiner, Joshua A.
Wieland-Alter, Wendy
Lee, Jiwon
Bloch, Evan M.
Tobian, Aaron A. R.
Redd, Andrew D.
Blankson, Joel N.
Wolf, Dana
Goetghebuer, Tessa
Marchant, Arnaud
Connor, Ruth, I
Wright, Peter F.
Ackerman, Margaret E.
ELIFE, 2022, 11
[36] SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
Narowski, Tara M.
Raphel, Kristin
Adams, Lily E.
Huang, Jenny
Vielot, Nadja A.
Jadi, Ramesh
de Silva, Aravinda M.
Baric, Ralph S.
Lafleur, John E.
Premkumar, Lakshmanane
CELL REPORTS, 2022, 38 (05):
[37] Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
Sarah Lapidus
Feimei Liu
Arnau Casanovas-Massana
Yile Dai
John D. Huck
Carolina Lucas
Jon Klein
Renata B. Filler
Madison S. Strine
Mouhamad Sy
Awa B. Deme
Aida S. Badiane
Baba Dieye
Ibrahima Mbaye Ndiaye
Younous Diedhiou
Amadou Moctar Mbaye
Cheikh Tidiane Diagne
Inés Vigan-Womas
Alassane Mbengue
Bacary D. Sadio
Moussa M. Diagne
Adam J. Moore
Khadidiatou Mangou
Fatoumata Diallo
Seynabou D. Sene
Mariama N. Pouye
Rokhaya Faye
Babacar Diouf
Nivison Nery
Federico Costa
Mitermayer G. Reis
M. Catherine Muenker
Daniel Z. Hodson
Yannick Mbarga
Ben Z. Katz
Jason R. Andrews
Melissa Campbell
Ariktha Srivathsan
Kathy Kamath
Elisabeth Baum-Jones
Ousmane Faye
Amadou Alpha Sall
Juan Carlos Quintero Vélez
Michael Cappello
Michael Wilson
Choukri Ben-Mamoun
Richard Tedder
Myra McClure
Peter Cherepanov
Fabrice A. Somé
Scientific Reports, 12
[38] Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
Lapidus, Sarah
Liu, Feimei
Casanovas-Massana, Arnau
Dai, Yile
Huck, John D.
Lucas, Carolina
Klein, Jon
Filler, Renata B.
Strine, Madison S.
Sy, Mouhamad
Deme, Awa B.
Badiane, Aida S.
Dieye, Baba
Ndiaye, Ibrahima Mbaye
Diedhiou, Younous
Mbaye, Amadou Moctar
Diagne, Cheikh Tidiane
Vigan-Womas, Ines
Mbengue, Alassane
Sadio, Bacary D.
Diagne, Moussa M.
Moore, Adam J.
Mangou, Khadidiatou
Diallo, Fatoumata
Sene, Seynabou D.
Pouye, Mariama N.
Faye, Rokhaya
Diouf, Babacar
Nery, Nivison
Costa, Federico
Reis, Mitermayer G.
Muenker, M. Catherine
Hodson, Daniel Z.
Mbarga, Yannick
Katz, Ben Z.
Andrews, Jason R.
Campbell, Melissa
Srivathsan, Ariktha
Kamath, Kathy
Baum-Jones, Elisabeth
Faye, Ousmane
Sall, Amadou Alpha
Velez, Juan Carlos Quintero
Cappello, Michael
Wilson, Michael
Ben-Mamoun, Choukri
Tedder, Richard
McClure, Myra
Cherepanov, Peter
Some, Fabrice A.
SCIENTIFIC REPORTS, 2022, 12 (01)
[39] Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2
Osaka, Toshifumi
Yamamoto, Yoko
Soma, Takehisa
Yanagisawa, Naoko
Nagata, Satoru
MICROORGANISMS, 2023, 11 (02)
[40] Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus
Papaneophytou, Christos
Nicolaou, Andria
Pieri, Myrtani
Nicolaidou, Vicky
Galatou, Eleftheria
Sarigiannis, Yiannis
Pantelidou, Markella
Panayi, Pavlos
Thoma, Theklios
Stavraki, Antonia
Argyrou, Xenia
Kalogiannis, Tasos
Yiannoukas, Kyriacos
Petrou, Christos C.
Felekkis, Kyriacos
PLOS ONE, 2022, 17 (06):

← 1 2 3 4 5 →